Apex Clinical Research Center
Mayfield Heights, Ohio 44124-4005
4 studies enrolling now · 18 studies all time
What they study most
Atopic Dermatitis, Atopic Dermatitis (AD), Chronic Spontaneous Urticaria, Cutaneous Lichen Planus, Gorlin Syndrome, Hidradenitis Suppurativa, Hidradenitis Suppurativa (HS), Moderate to Severe Chronic Plaque Psoriasis, Palmoplantar Pustulosis, Plaque Psoriasis, Prurigo Nodularis (PN), Psoriasis
Studies at this site
- Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis — Recruiting now
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
- A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis — Recruiting now
- A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis — Recruiting now
- A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Running, not enrolling
- Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense — Running, not enrolling
- A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
- A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
- An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis — Stopped early
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
- Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum — Stopped early
- Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome — Running, not enrolling
- Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis — Completed
- Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis — Completed
- Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) — Completed
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus — Completed
- Study to Assess the Efficacy and Safety of Orismilast in Psoriasis — Completed
- A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) — Stopped early